EarningsQ2 2024 Earnings Report

Rhythm Pharmaceuticals (RYTM) Q2 2024 Earnings Report

1 Followers

MX:RYTM Q2 2024 EPS Results

Actual EPS-$9.50

Consensus EPS-$12.24

Beat/MissBeat by +$2.75

One Year Ago EPS-$14.16

Actual Revenue$502.05M

Expected Revenue$497.07M

Beat/MissBeat by +$4.97M

YoY Revenue Growth+51.28%

QuarterQ2 2024

Date08/06/2024

TimeBefore Open

Conference CallTuesday, August 6, 2024

MX:RYTM Upcoming Earnings

Rhythm Pharmaceuticals's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

MX:RYTM Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-12.48 / -	-14.158	―
Aug 04, 2026	2026 (Q2)	-13.93 / -12.60	-12.949	2.67% (+0.35)
May 05, 2026	2026 (Q1)	-14.19 / -14.33	-13.985	-2.47% (-0.35)
Feb 26, 2026	2025 (Q4)	-13.90 / -12.60	-12.431	-1.39% (-0.17)
Nov 04, 2025	2025 (Q3)	-12.22 / -14.16	-12.604	-12.33% (-1.55)
Aug 05, 2025	2025 (Q2)	-11.57 / -12.95	-9.496	-36.36% (-3.45)
May 07, 2025	2025 (Q1)	-11.98 / -13.99	-40.574	65.53% (+26.59)
Feb 26, 2025	2024 (Q4)	-11.98 / -12.43	-12.086	-2.86% (-0.35)
Nov 05, 2024	2024 (Q3)	-13.90 / -12.60	-13.122	3.95% (+0.52)
Aug 06, 2024	2024 (Q2)	-12.24 / -9.50	-14.158	32.93% (+4.66)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed